Related scientific articles (all)

The European lung corner.

Authors : Sculier JP
Year : 2013
Journal : Eur. Respir. J.
Volume : 42(6)
Pages : 1433-4

Targeting RANKL in breast cancer: bone metastasis and beyond.

Authors : Azim H, Azim HA
Year : 2013
Journal : Expert Rev Anticancer Ther
Volume : 13(2)
Pages : 195-201

Desire for formal psychological support among caregivers of patients with cancer: prevalence and implications for screening their needs. (epub online 2012)

Authors : Merckaert I, Libert Y, Lieutenant F, Moucheux A, Farvacques C, Slachmuylder JL, Razavi D
Year : 2013
Journal : Psychooncology
Volume : 22(6)
Pages : 1389-95

Magnitude of Trastuzumab Benefit in Patients With HER2-Positive, Invasive Lobular Breast Carcinoma: Results From the HERA Trial.

Authors : Metzger-Filho O, Procter M, de Azambuja E, Leyland-Jones B, Gelber Rd, Dowsett M, Loi S, Saini KS, Cameron D, Untch M, Smith I, Gianni L, Baselga J, Jackisch C, Bell R, Sotiriou C, Viale G, Piccart-Gebhart M
Year : 2013
Journal : J. Clin. Oncol.
Volume : 31(16)
Pages : 1954-60

Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience.

Authors : Metzger-Filho O, de Azambuja E, Bradbury I, Saini KS, Bines J, Simon SD, Dooren VV, Aktan G, Pritchard KI, Wolff AC, Smith I, Jackisch C, Lang I, Untch M, Boyle F, Xu B, Baselga J, Perez EA, Piccart-Gebhart M
Year : 2013
Journal : Oncologist
Volume : 18(2)
Pages : 134-40

A Randomized Study of Interferon a-2b Versus No Treatment as Consolidation After High Dose Therapy and Autologous Stem Cell Transplantation for Patients With Relapsed Lymphoma.

Authors : Bosly A, Grigg A, Holte H, Gisselbrecht C, Radford J, Rossi A, Lopez-Guillermo A, Trneny M, Sebban C, Hagberg H, Leal da Costa F, Colombat P, Bron D, Coiffier B
Year : 2013
Journal : Oncologist
Volume : 18(11)
Pages : 1189

Multigene assays for late recurrence of breast cancer.

Authors : Ignatiadis M
Year : 2013
Journal : Lancet Oncol
Volume : 14(11)
Pages : 1029-30

Radioembolization of the Spleen: A Revisited Approach for the Treatment of Malignant Lymphomatous Splenomegaly. (epub online 2012)

Authors : Muylle K, Nguyen J, de Wind A, Meuleman N, Delatte P, Vanderlinden B, Roelandts M, Vanderstappen A, Bron D, Flamen P
Year : 2013
Journal : Cardiovasc Intervent Radiol
Volume : 36(4)
Pages : 1155-60

Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.

Authors : Goss PE, Smith IE, + collaborators (among others :, Piccart-Gebhart M, Finkelstein DM
Year : 2013
Journal : Lancet Oncol
Volume : 14(1)
Pages : 88-96

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement.

Authors : Azim HA, Michiels S, Zagouri F, Delaloge S, Filipits M, Namer M, Neven P, Symmans WF, Thompson A, André F, Loi S, Swanton C
Year : 2013
Journal : Ann Oncol
Volume : 24(3)
Pages : 647-54

Beyond trastuzumab and lapatinib: new options for HER2-positive breast cancer .

Authors : Zardavas D, Cameron D, Krop I, Piccart-Gebhart M
Year : 2013
Journal : Am Soc Clin Oncol Educ Book
Volume : null(null)

Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells.

Authors : André T, Meuleman N, Stamatopoulos B, De Bruyn C, Pieters K, Bron D, Lagneaux L
Year : 2013
Journal : PLoS One
Volume : 8(3)
Pages : e59756

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98.

Authors : Loi S, Sirtaine N, Piette F, Salgado R, Viale G, Van Eenoo F, Rouas G, Francis P, Crown JP, Hitre E, de Azambuja E, Quinaux E, Di Leo A, Michiels S, Piccart-Gebhart M, Sotiriou C
Year : 2013
Journal : J. Clin. Oncol.
Volume : 31(7)
Pages : 860-7

Rational approach of leucocytosis in adults].

Authors : Bron D
Year : 2013
Journal : Rev Med Brux
Volume : 34(4)
Pages : 339-42

Genomic grade adds prognostic value in invasive lobular carcinoma.

Authors : Metzger-Filho O, Michiels S, Bertucci F, Catteau A, Salgado R, Galant C, Fumagalli D, Singhal SK, Desmedt C, Ignatiadis M, Haussy S, Finetti P, Birnbaum D, Saini KS, Berlière M, Veys I, de Azambuja E, Bozovic I, Peyro-Saint-Paul H, Larsimont D, Piccart-Gebhart M, Sotiriou C
Year : 2013
Journal : Ann Oncol
Volume : 24
Pages : 377-384

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting.

Authors : Peeters DJ, De Laere B, Van den Eynden GG, Van Laere SJ, Rothé F, Ignatiadis M, Sieuwerts AM, Lambrechts D, Rutten A, van Dam PA, Pauwels P, Peeters M, Vermeulen PB, Dirix LY
Year : 2013
Journal : Br J Cancer
Volume : 108(6)
Pages : 1358-67

Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023.

Authors : Kerklaan BM, Diéras V, Le Tourneau C, Mergui-Roelvink M, Huitema AD, Rosing H, Beijnen JH, Marreaud S, Govaerts AS, Piccart-Gebhart M, Schellens JH, Awada A
Year : 2013
Journal : Cancer Chemother Pharmacol
Volume : 71(1)
Pages : 53-62

Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: how should we counsel cancer patients about breastfeeding?

Authors : Pistilli B, Bellettini G, Giovannetti E, Codacci-Pisanelli G, Azim HA, Benedetti G, Sarno MA, Peccatori FA
Year : 2013
Journal : Cancer Treat Rev
Volume : 39(3)
Pages : 207-11

Emerging targeted agents in metastatic breast cancer.

Authors : Zardavas D, Baselga J, Piccart-Gebhart M
Year : 2013
Journal : Nat Rev Clin Oncol
Volume : 10(4)
Pages : 191-210

Impact of different mesenchymal stromal cell types on T-cell activation, proliferation and migration.

Authors : Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, Lagneaux L
Year : 2013
Journal : Int. Immunopharmacol.
Volume : 15(4)
Pages : 693-702